Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 3-(3-cyano-4-carboxymethyl-5-carboxy-2-thienyl)-3-azapentanedioic Distrontium Salt
2. Protelos
3. S 12911
4. S-12911
5. S12911
6. S12911-0
7. S12911-2
8. S12911-5
9. Strontium Ranelate
1. Distrontium Renelate Octahydrate
2. 674773-15-0
3. 8pd4806e06
4. Strontium Ranelate
5. 3-thiopheneacetic Acid, 5-(bis(carboxymethyl)amino)-2-carboxy-4-cyano-, Strontium Salt (1:2), Octahydrate
6. Unii-8pd4806e06
7. Dtxsid00217833
8. Q27270857
Molecular Weight | 657.6 g/mol |
---|---|
Molecular Formula | C12H22N2O16SSr2 |
Hydrogen Bond Donor Count | 8 |
Hydrogen Bond Acceptor Count | 19 |
Rotatable Bond Count | 4 |
Exact Mass | 657.8802283 g/mol |
Monoisotopic Mass | 657.8802283 g/mol |
Topological Polar Surface Area | 224 Ų |
Heavy Atom Count | 33 |
Formal Charge | 0 |
Complexity | 533 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 11 |
Bone Density Conservation Agents
Agents that inhibit BONE RESORPTION and/or favor BONE MINERALIZATION and BONE REGENERATION. They are used to heal BONE FRACTURES and to treat METABOLIC BONE DISEASES such as OSTEOPOROSIS. (See all compounds classified as Bone Density Conservation Agents.)
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?